Shanghai Aoxuan Biopharmaceutical Technology

Shanghai Aoxuan Biopharmaceutical Technology is a biotechnology company based in Shanghai, China, specializing in the discovery and development of innovative small molecule therapeutics. Founded in 2021, the company focuses on addressing unmet medical needs in oncology, central nervous system (CNS) disorders, and metabolic diseases. It leverages advanced medicinal chemistry and high-throughput screening platforms to identify and optimize novel drug candidates. The company is closely associated with academic research from Shanghai Jiao Tong University, particularly the work of Professor Zhang Ao. Aoxuan Biopharmaceutical aims to bridge the gap between basic scientific research and clinical application through its internal R&D capabilities and strategic collaborations.